Piramal Pharma Solutions, a CDMO and part of Piramal Pharma Ltd., announced a $90 million investment plan to expand two of ...

Pharmaceutical partners are now repeatedly seeking to become integrated care providers, wanting to play a bigger supporting role and thus are investing in services alongside their product offering.

West Pharmaceutical Services Inc. closed 38.11% below its 52-week high of $352.33, which the company reached on October 24th.

West Pharmaceutical Services beat analysts’ revenue expectations by 1.2% last quarter, reporting revenues of $748.8 million, up 2.3% year on year. It was a softer quarter for the company, ...

RFK Jr. is attempting to curb pharma ad spending, according to Bloomberg. One expert and former senior HHS official thinks ...

PCI Pharma Services (“PCI”) – a leading global contract development and manufacturing organization (CDMO) focused on innovative biopharma therapies – is acqu ...

A high-level overview of West Pharmaceutical Services, Inc. (WST) stock. View (WST) real-time stock price, chart, news, analysis, analyst reviews and more.

Pharma companies are expending considerable time, energy and money on developing services that are designed to support patients before, during and after treatment across therapeutic areas.

Learn about the executive team and board of directors at West Pharmaceutical Services Inc (WST:XNYS) and review their bios and compensation over the latest fiscal years.

West Pharmaceutical Services shares have dropped 35% in 2025, despite better-than-expected Q1 results, with forward guidance also was boosted slightly. Learn more on WST stock here.

West Pharmaceutical Services gets about half of it sales from markets outside of the United States. Related Articles . Partners in Philanthropy: 25 partnerships changing the region ...

West Pharmaceutical Services beat analysts’ revenue expectations by 1.2% last quarter, reporting revenues of $748.8 million, up 2.3% year on year. It was a softer quarter for the company, ...